Should You Invest In These 5%+ Yielders? Anglo American plc, GlaxoSmithKline plc, Telecom Plus PLC & Admiral Group plc

Royston Wild explains the investment appeal of Anglo American plc (LON: AAL), GlaxoSmithKline plc (LON: GSK), Telecom plus PLC (LON: TEP) and Admiral Group plc (LON: ADM).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am looking at whether you should stash your cash in these four big-yield behemoths.

Anglo American

At first glance Anglo American (LSE: AAL) may be an attractive pick for those seeking brilliant investment returns. According to City forecasts the mining colossus is set to deliver a dividend of 85 US cents per share in both 2015 and 2016, matching the payouts seen in the past three periods. Consequently the business offers a market-beating yield of 5.4% through to the close of next year.

But I believe that these predictions may fall short of estimates, as severe supply/demand imbalances across its critical markets threaten a fourth successive earnings slide for this year and potentially beyond. With Anglo American also nursing a $12.9bn net debt pile as of the turn of 2015 — and prospective dividends covered just 1.2 times and 1.6 times for this year and next, well below the safety market of 2 times — I believe the metals play is a perilous pick for income seekers.

GlaxoSmithKline

Conversely, I believe that GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) is a strong dividend pick for the near term and stretching further ahead. The pharma giant announced plans last month to fork out an ordinary dividend of 80p per share through to the close of 2017, forecasts that carry a chunky yield of 5.4%.

Like Anglo American, GlaxoSmithKline boasts poor dividend cover for the next few years, with projected earnings of 81.9p for 2015 and 89.5p for next year barely exceeding expected dividends. But the Brentford firm remains a brilliant cash generator despite the effect of expiring patents on profits, and is also undertaking massive restructuring to bolster the balance sheet and cut the debt column still further. And with GlaxoSmithKline’s revitalised R&D department ready to drive revenues higher again from this year, I expect dividends to continue outperforming the wider market.

Telecom Plus

Shares in Telecom Plus (LSE: TEP) have gradually stepped lower in recent months as gas and electricity prices have headed steadily lower. However, the business is expected keep the likes of Centrica, SSE et al on the back foot by continually improving its tariff range —  as illustrated by March’s new two-year tariff, part-funded by nPower — while Telecom Plus’ strategy of rewarding existing customers rather than courting new clients is also helping to maintain its consumer base.

As a consequence Telecom Plus is expected to see earnings tick comfortably higher through the next few years at least, driving a predicted dividend of 40p per share for the year concluding March 2015 to 46p in 2016 and to 52p the following year. Consequently the business boasts vast yields of 5.7% for this year and 6.4% for 2017.

Admiral Group

Although car insurance specialist Admiral (LSE: ADM) remains beset by intense competition, I believe that a gradual improvement in premiums should keep dividends bubbling along at above-average levels. This view is shared by the City, and the Swansea-based firm is expected to fork out rewards of 89.1p this year and 94.8p in 2016. As a result the insurer carries gigantic yields of 6% and 6.4% for these years.

While dividend coverage may be lacking over at Admiral — estimated payments are barely covered by earnings through to the end of next year — the firm is a terrific capital generator and saw cash and cash equivalents leap to £255.9m last year from £187.9m in 2013. With its operations on mainland Europe also pulling up trees, and Admiral boasting terrific customer retention rates, I believe the Cardiff firm should remain a lucrative payout pick.

 

Royston Wild has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline and Centrica. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Aston Martin DBX - rear pic of trunk
Investing Articles

There are hundreds of shares I’d rather buy than Aston Martin. Here’s why!

Aston Martin shares sell for pennies yet some of its cars can cost millions. So why doesn't this writer see…

Read more »

Young Caucasian man making doubtful face at camera
Investing Articles

3 risks to Greggs shares that could hamper a recovery

Greggs shares have a good dividend, but the price has performed weakly. Is our writer missing something by holding onto…

Read more »

ISA coins
Investing Articles

1 mighty FTSE dividend stock I’m considering for my ISA

A new ISA allowance has Paul Summers searching for strong and stable dividend stocks to add to his portfolio.

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Are Rolls-Royce shares’ best days behind them?

Rolls-Royce shares have had a stellar few years. So far in 2026, though, they slightly lag the FTSE 100 blue-chip…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

Buying £20k of Lloyds shares could give me an £851 income this year!

Lloyds has been one of the FTSE 100's hottest dividend growth shares in recent years. But do current risks make…

Read more »

Picturesque Cotswold village of Castle Combe, England
Investing Articles

ISA or SIPP? Some key differences to know

Ever wondered what some of the differences are between investing for retirement in a SIPP and in an ISA? Here…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

2 world-class S&P 500 stocks down 11% and 32% to consider buying

Searching for stocks to buy for an ISA in April? Our writher thinks these excellent growth shares are worth a…

Read more »

View over Old Man Of Storr, Isle Of Skye, Scotland
Investing Articles

How much do you need in a Stocks and Shares ISA to aim for an annual income of £39,477?

Harvey Jones shows how ordinary investors can use their Stocks and Shares ISA allowance to build a generous passive income…

Read more »